According to the Catalogue of somatic mutations in cancer, the occurrence of mutations in the PI3K/Akt pathway are more likely in follicular and anaplastic thyroid cancers but on the other hand are less frequent in papillary thyroid cancer. This evidence concerns the gene AKT1 and cancer.